These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3116314)

  • 41. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Heart failure and cardiac arrhythmias].
    Rostock KJ
    Z Kardiol; 1991; 80 Suppl 8():27-30. PubMed ID: 1796633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Electrophysiological action of disopyramide].
    Grosu AA; Malakhov VI; Smetnev AS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):51-5. PubMed ID: 7138657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of amiodarone and disopyramide on the results of electrocardiographic exercise stress testing in patients with coronary disease].
    Dabrowski A; Ostrowska B; Bacior B; Fryśna-Dmuchowska B; Kargul W; Król J; Królikowski Z; Luczak D; Malczewska B; Nessler J
    Kardiol Pol; 1990 Mar; 33(3):165-72. PubMed ID: 2082070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 47. Disopyramide: a new agent for effective therapy of ventricular dysrhythmias.
    Mason DT
    Drugs; 1978 May; 15(5):329-30. PubMed ID: 657990
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
    Kus T; Sasyniuk BI
    J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of the variation pulsimetry in the evaluation of diurnal dynamics of cardiac rhythm in patients with ischemic heart disease and functional disorders of the cardiovascular system].
    Baevskiĭ RM; Smirnova TM
    Kardiologiia; 1978 Apr; 18(4):44-51. PubMed ID: 566808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias.
    Paulk EA
    Angiology; 1987 Feb; 38(2 Pt 2):198-204. PubMed ID: 3103494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study of the effects of oxprenolol on pain and on electrocardiographic changes in patients with ischemic heart disease].
    Contino A
    G Clin Med; 1979 May; 60(5):402-8. PubMed ID: 488590
    [No Abstract]   [Full Text] [Related]  

  • 52. Cardiac electrophysiologic alterations during myocardial ischemia.
    Elharrar V; Zipes DP
    Am J Physiol; 1977 Sep; 233(3):H329-45. PubMed ID: 333943
    [No Abstract]   [Full Text] [Related]  

  • 53. Coronary artery disease and major conduction disturbances. A pathologic study designed to correlate vascular and conduction system abnormalities with electrocardiogram.
    Harper JR; Harley A; Hackel DB; Estes EH
    Am Heart J; 1969 Mar; 77(3):411-22. PubMed ID: 5766727
    [No Abstract]   [Full Text] [Related]  

  • 54. Preventing ventricular arrhythmias in ischemic heart disease.
    Ruffy R; Zipes DP
    Geriatrics; 1979 Jan; 34(1):21-5. PubMed ID: 103780
    [No Abstract]   [Full Text] [Related]  

  • 55. [The use of verapamil in suppositories for treating patients with ischemic heart disease].
    Shkliar MB; Soleĭko MB; Alekseeva IP; Kul'chevich LV
    Vrach Delo; 1990 Aug; (8):13-5. PubMed ID: 2256273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiarrhythmic drug therapy.
    Stanford JL; Felner JM; Arensberg D
    Am J Nurs; 1980 Jul; 80(7):1288-95. PubMed ID: 6901576
    [No Abstract]   [Full Text] [Related]  

  • 57. Exercise and arrhythmia.
    Murayama M; Shimomura K
    Jpn Circ J; 1979 Mar; 43(3):247-56. PubMed ID: 449028
    [No Abstract]   [Full Text] [Related]  

  • 58. [Anti-arrhythmia effect of disopyramide].
    Olbermann M; Just H; Guckenbiehl H; Lang KF
    Verh Dtsch Ges Inn Med; 1975; 81():152-5. PubMed ID: 1229482
    [No Abstract]   [Full Text] [Related]  

  • 59. [Changes in thrombocyte-vascular hemostasis and cyclic nucleotide levels after anti-arrhythmia therapy in patients with ischemic heart disease].
    Liusov VA; Dudaev VA; Borodkin VV; Rudakov AV
    Kardiologiia; 1989 Jan; 29(1):9-13. PubMed ID: 2733320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Results of long-term electrocardiographic monitoring of patients with ischemic heart disease].
    Dudchenko MA; Potiazhenko MM; Kulishov SK
    Vrach Delo; 1988 Jun; (6):13-5. PubMed ID: 3420901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.